AbbVie Inc. (ABBV): $118.19

0.65 (+0.55%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

AbbVie Inc (ABBV) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering AbbVie Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
20 $127 $97 $112.05 $116.05 -3.45%

The Trend in the Analyst Price Target


Over the past 100 days, ABBV's average price target has gone up $1.72.

Over the past 175 days, ABBV's average upside potential has been 16.92%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2020-11-30 20 127 97 112.05 104.58 7.14%
2020-11-17 20 127 97 111.45 99.21 12.34%
2020-11-10 19 127 97 110.84 98.87 12.11%
2020-10-21 18 127 96 109.61 82.89 32.24%
2020-09-30 17 127 96 109.29 87.59 24.77%
2020-09-10 16 127 96 110.00 89.65 22.7%
2020-09-01 16 127 96 110.00 92.24 19.25%
2020-08-23 15 127 96 110.33 94.86 16.31%
2020-08-22 15 127 96 110.33 94.86 16.31%
2020-08-12 15 127 95 109.47 95.51 14.62%
2020-08-03 14 127 95 110.14 95.94 14.8%
2020-07-22 14 125 93 107.93 97.70 10.47%
2020-07-17 14 125 93 107.93 NA NA%
2020-07-02 14 125 91 107.64 NA NA%
2020-06-24 15 125 70 104.53 NA NA%
2020-06-16 15 122 70 101.27 NA NA%
2020-06-09 15 122 70 100.40 NA NA%
2020-06-08 14 122 70 98.71 NA NA%

ABBV Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs

The Trend in the Broker Recommendations


Over the past 61 days, ABBV's average broker recommendation rating worsened by 0.03.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for ABBV as an investment opportunity.

  • The number of analysts covering the stock of ABBV is higher than 93.61% of all US stocks.
  • ABBV has a higher average analyst price target than 93.74% of Pharmaceutical Products stocks.
  • AbbVie Inc's upside potential (average analyst target price relative to current price) is higher than 6.54% of Pharmaceutical Products stocks.
  • ABBV has a less variance in analysts' estimates than 80.36% of stocks in the mega market cap category.

Make investment decisions regarding ABBV using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6775 seconds.